Industrifonden is a venture capital firm based in Stockholm, Sweden, founded in 1979. The firm specializes in early-stage investments in small and medium-sized enterprises, particularly within the technology and life science sectors. It focuses on a wide range of technology areas, including internet and media, information technology, telecommunications, automation, robotics, deep tech, and cleantech. In life sciences, Industrifonden targets pharmaceuticals and medical technology. The firm typically invests between SEK 5 million and SEK 100 million in companies with annual revenues up to SEK 400 million. As an active minority investor, Industrifonden seeks ownership stakes of 15 to 50 percent and often takes a board seat. It provides financing through equity capital, loans, and guarantees, and prefers to co-invest with other regional venture capital firms. The firm's investment strategy aims for exits within five to ten years, either through sales to industry players or initial public offerings. Additionally, Industrifonden maintains offices in Malmö, Linköping, and Gothenburg, contributing to its extensive support for entrepreneurs in Sweden.
Senior Investment Director and Practice Lead Transformative Tech
Iliam Barkino
Principal
Tomas Bie
Investment Director
Karolina Bjurehed
Investment Director
Jonas Brambeck Ph.D
Senior Investment Director
Hadar Cars
Senior Investment Director
Tobias Elmquist
Senior Investment Director
Tobias Elmquist
Senior Investment Director
Anna Haupt
Investment Director
Jonathan Ilicki
Principal
Anna Ljungdahl
Senior Investment Director
Caroline Murray
CFO
Anders Slettengren
CEO
Patrik Sobocki Ph.D
Senior Investment Director and Practice Lead Deep Tech
Andreas Söneby
Venture Partner
Tore Tolke
Investment Manager Technology
Mala Valroy
Investment Manager
Caroline Wachtmeister
Principal
Peter Wolpert
CEO
Matti Zemack
Investment Director
Sara Frykstrand Ångström
Associate
Caroline Wadstein
Investor
211 past transactions
Tribune Therapeutics
Series A in 2025
Tribune Therapeutics is a preclinical biopharmaceutical company dedicated to developing innovative medicines for the treatment of various fibrotic diseases. The company focuses on creating therapies that target the CCN protein family, a group of signaling proteins that play a crucial role in the development of fibrosis. By concentrating on these specific proteins, Tribune Therapeutics aims to provide effective treatment options for patients suffering from fibrotic conditions.
Novatron
Series A in 2025
Novatron is focused on developing a proprietary fusion power concept aimed at producing clean, sustainable energy. Collaborating with physicists, engineers, and academic institutions, the company seeks to create an energy system that not only reduces reliance on fossil fuels but also minimizes greenhouse gas emissions. By advancing fusion energy technology, Novatron aims to provide abundant and renewable energy solutions, contributing to a more sustainable future for humanity.
Gårdsfisk
Series A in 2025
Gårdsfisk AB, founded in 2013 and based in Åhus, Sweden, specializes in innovative land-based fish farming. The company has developed a unique method that utilizes large tanks within a closed system, allowing for the cultivation of fish while minimizing environmental impact. This approach enables the recycling of nutrient-rich wastewater as fertilizer for agricultural fields, enhancing sustainability. By providing farmers with the technology to breed fish domestically, Gårdsfisk aims to address the environmental challenges associated with traditional fish farming practices, promoting a more sustainable aquaculture industry.
Echandia
Venture Round in 2025
Echandia specializes in energy storage solutions and battery systems primarily for maritime transportation, shipping, and heavy-duty applications. The company offers advanced battery technologies, including Lithium-Titanate-Oxide (LTO) systems, which are known for their exceptional safety, rapid charging capabilities—achieving a full charge in approximately 10 minutes—and an impressive lifespan exceeding 30,000 cycles. Their Echandia Energy system is an air-cooled lithium-ion battery designed specifically for long-term maritime use, ensuring both safety and efficiency. Additionally, the Echandia Power system is optimized for hybrid applications, providing high power output for short durations, typically lasting five minutes or less. By focusing on zero-emission energy solutions, Echandia enables clients to adopt sustainable energy sources across various operations, including maritime, rail, and wind power.
Fibbl
Venture Round in 2025
Fibbl is a pioneering visual marketing platform that specializes in 3D and augmented reality services, aimed at enhancing e-commerce and marketing efforts for businesses. By offering a cost-effective, end-to-end solution, Fibbl enables users to integrate photorealistic 3D models of consumer products into their marketing strategies in a matter of minutes. The company boasts the world's largest database of 3D models, encompassing a wide array of products from well-known global brands. This innovative approach streamlines the production process, making it easier for businesses to adopt advanced visual marketing techniques that enhance customer engagement and drive sales.
Senseworks
Venture Round in 2025
Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.
Agteria Biotech
Seed Round in 2025
Agetria Biotech is a biotech startup that specializes in agricultural solutions, providing sustainable feed additives for livestock. The company provides a distinctive feed additive aimed at enhancing the overall health and well-being of livestock, simultaneously decreasing methane emissions. This fosters a more sustainable livestock farming industry, empowering customers to boost animal health, potentially leading to increased productivity and reduced reliance on antibiotics.
Open Payments
Venture Round in 2025
Open Payments Europe is a developer of an open banking platform that facilitates secure access to various bank API networks across Europe. Established in 2017 and based in Stockholm, Sweden, the company offers a PSD2 compliant API aggregation platform, ensuring a unified and secure point of access for users. The platform is designed to allow third-party providers and business partners to create and manage their own products and services while maintaining control over the user experience. By using multi-language support and sample integrations, Open Payments enables businesses to seamlessly connect with banks and financial services, thereby enhancing the efficiency of their operations and fostering innovation in the financial sector.
Gesynta Pharma
Series B in 2025
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.
AnaCardio
Series A in 2025
AnaCardio is a clinical-stage biopharmaceutical company focused on developing innovative drugs for the treatment of heart failure. The company’s therapeutic drugs aim to enhance the contractility of the heart muscle through a unique mechanism involving a therapeutic peptide. This approach is designed to avoid common adverse effects associated with heart treatments, such as tachycardia, arrhythmia, ischemia, and hypotension. By improving cardiac output safely, AnaCardio's therapies have the potential to enhance organ function, boost quality of life, increase functional capacity, and reduce the risk of hospitalization and mortality in patients with heart failure.
Avassa
Venture Round in 2024
Avassa is a developer of a distributed cloud management platform focused on managing applications across various edge locations. The platform facilitates secure and remote updates, monitoring, and troubleshooting of edge applications, streamlining application orchestration while adhering to a zero-trust security model. By bridging the gap between containerized application development and operations, Avassa's solution allows businesses to deploy teams, monitor workloads, and manage the lifecycle of edge applications efficiently and securely. This approach empowers organizations to operate at the speed of software while ensuring robust management in diverse environments.
Saltx Technology Holding
Post in 2024
SaltX Technology Holding AB specializes in the development and sale of innovative energy storage solutions. The company has created and patented a groundbreaking technology that enables the storage of energy in salt crystals. This unique approach allows for efficient conversion of stored energy into heating and cooling applications. By leveraging the properties of salt, SaltX aims to provide sustainable energy storage options that contribute to the future of energy management.
BOOST Pharma
Venture Round in 2024
BOOST Pharma is a biotechnology research company focused on developing a stem cell therapy for osteogenesis imperfecta, a genetic disorder characterized by fragile bones. Founded in 2019 and headquartered in Copenhagen, Denmark, the company utilizes innovative mesenchymal stem cells known for their high bone-forming capabilities. Upon injection, these stem cells migrate to the patient's bone, where they engraft and initiate new bone formation. This therapeutic approach aims to enable clinicians to address the disease at its earliest stages, potentially enhancing patient outcomes over time.
ZeroPoint Technologies
Series A in 2024
ZeroPoint Technologies specializes in advanced memory compression technology that enhances energy efficiency and performance in data centers and smart devices. As energy consumption in the ICT sector rises, ZeroPoint's solutions address the need for improved performance per watt by eliminating unnecessary information from microchips. Their technology, which combines rapid data compression, real-time data compaction, and effective memory management, can deliver up to 50% more performance per watt. This innovation not only allows data centers to optimize energy usage but also enables smart device developers to enhance user experience without sacrificing battery life. With a strong patent portfolio and a foundation rooted in high-performance computing research, ZeroPoint collaborates with leading industry players to integrate its hardware IP into system-on-chip designs. The company, established by experts from academia and industry, has attracted talent from various sectors and successfully raised venture capital to support its growth and technological advancements.
Arevo specializes in the development of biostimulants and plant nutrition products, primarily focusing on the cultivation of forest plants such as pine and spruce. The company's innovative technologies include liquid and granular amino acid fertilizers that enhance plant establishment and growth. Arevo's specialized fertilizers not only promote improved growth but also significantly impact plant survival and carbon sequestration. By fostering robust root systems, their products help make plants more stress-resistant, thereby simplifying the cultivation process for producers.
Asgard Therapeutics
Series A in 2024
Asgard Therapeutics is a private biotech company focused on developing innovative cancer immunotherapies through direct cell reprogramming technologies. Emerging as a spin-off from Lund University, the company utilizes its proprietary TrojanDC technology to initiate immune responses by leveraging the unique properties of professional antigen-presenting cells. This approach aims to create efficient and personalized gene therapy products that activate robust anti-cancer immune defenses. By offering off-the-shelf solutions, Asgard Therapeutics seeks to provide new treatment options for patients suffering from cancers that are resistant to traditional therapies, thereby expanding the possibilities for effective cancer treatment.
Apica
Venture Round in 2024
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.
TrusTrace
Series B in 2024
TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.
Texray
Venture Round in 2023
Texray AB specializes in the development of radiation protection textiles specifically designed for medical practitioners who use X-rays during surgical procedures. The company has created a unique woven material with an attenuating capacity that effectively shields users from harmful radiation. This innovative product not only prioritizes the health and safety of medical professionals but also enhances their ability to perform life-saving interventions. Through its patented technology platform, Texray aims to revolutionize radiation protection in the medical field.
MinervaX
Venture Round in 2023
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.
Fast Travel Games
Venture Round in 2023
Fast Travel Games is a game development studio based in Stockholm, Sweden, specializing in virtual reality (VR) games. Founded by experienced professionals from notable studios such as EA DICE, Rovio, and Avalanche, the company aims to transform the gaming experience through immersive VR environments. They focus on creating games that promote exploration, rich narratives, and social interaction, allowing players to engage with their surroundings and each other in innovative ways. Fast Travel Games is dedicated to delivering engaging experiences that enhance the way players connect with gaming universes.
Cellevate
Seed Round in 2023
Cellevate AB is a biotech company based in Lund, Sweden, founded in 2014. It specializes in developing advanced 3D cell culture systems utilizing nanofiber scaffolds known as 3D NanoMatrix. These scaffolds facilitate the creation of realistic in-vitro models, which are essential for scientific research and development across various fields, including automotive, construction, defense, electronics, energy, environment, and healthcare. Cellevate's platform employs a patented manufacturing process to produce consistent and porous networks of nanofibers, enhancing the effectiveness of cell culture systems and supporting upstream bioprocessing efforts.
Pixelgen Technologies
Series A in 2023
Pixelgen Technologies is a company focused on advancing biomedical research and diagnostics through the development of innovative bio-analytical tools. Founded in 2020 and based in Sweden, the firm specializes in creating novel analytical methods and products that enhance the understanding of biological processes. These tools are designed to provide researchers and drug developers with valuable insights into biomedicine, ultimately aiming to improve health outcomes. By delivering advanced solutions for biomedical analysis, Pixelgen Technologies plays a crucial role in supporting scientific discovery and development in the healthcare sector.
AlixLabs
Seed Round in 2023
AlixLabs specializes in nanostructure fabrication using atomic layer etching (ALE) technology. This innovative approach enables the production of nanostructures with sizes less than 20 nanometers, surpassing the limitations of traditional optical and electron beam lithography. By employing a damage-free etching process, AlixLabs facilitates the manufacturing of extremely small structures with high precision and efficiency, which is particularly beneficial for the semiconductor industry. The company's methods may also support the economically viable scaling of transistor channels for sub-20 nanometer technology nodes, positioning AlixLabs as a key player in advancing nanoelectronics.
Novatron
Seed Round in 2023
Novatron is focused on developing a proprietary fusion power concept aimed at producing clean, sustainable energy. Collaborating with physicists, engineers, and academic institutions, the company seeks to create an energy system that not only reduces reliance on fossil fuels but also minimizes greenhouse gas emissions. By advancing fusion energy technology, Novatron aims to provide abundant and renewable energy solutions, contributing to a more sustainable future for humanity.
Apica
Venture Round in 2023
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.
Fishbrain
Venture Round in 2023
Fishbrain is a mobile application and commerce platform designed for fishing enthusiasts. It serves as a social network that connects anglers globally, allowing users to share information about catches and fishing techniques. The app features an interactive map that helps users discover new fishing locations and see what other anglers are catching, including details on bait used and specific locations. Fishbrain promotes responsible fishing practices, encouraging catch and release as well as the sustainable harvest of fish species. Additionally, the platform offers tools and insights to enhance the fishing experience, supporting users in their pursuit of successful fishing adventures.
Virkesbörsen
Venture Round in 2023
Virkesbörsen has developed a digital marketplace for buying and selling wood in Sweden.
Hopsworks
Series B in 2023
Hopsworks, founded in 2016 and based in Stockholm, Sweden, is a developer of a data platform that focuses on artificial intelligence and machine learning. The company offers Hops Enterprise Services, which utilizes deep learning, stream processing, and SQL capabilities. Hopsworks provides an on-premise data management and data science platform called Hopsworks Enterprise, which includes tools for planning, pricing, and calculating return on investment for data scientists. The platform is designed to support the development and management of feature, training, and inference pipelines at scale, catering to diverse data teams and sources. Hopsworks specializes in technologies such as TensorFlow, Flink, MySQL, and HDFS, enabling clients to implement AI solutions for complex business challenges with optimal performance and availability.
Soundtrack Your Brand
Venture Round in 2023
Soundtrack Your Brand is a business-to-business music platform that allows small business owners to create and legally play tailored playlists in their venues. The platform offers a subscription-based service that grants access to a commercial catalog of songs, enabling businesses to play any music they choose without legal concerns. This service helps businesses enhance their digital media presence by curating playlists that suit various settings and events, ensuring a positive experience for both customers and employees. Soundtrack Your Brand aims to simplify the process of music selection for businesses, providing unlimited and customizable playlists during operational hours.
Retein
Venture Round in 2023
Retein is a water purification technology company focused on producing pure water at a low energy cost. Utilizing advanced materials and aquaporin proteins, Retein's technology effectively removes pollutants, including microplastics and pharmaceutical residues, from water. This innovative approach not only ensures the sustainable recovery of valuable resources but also promotes efficiency and cost-effectiveness for clients. By advancing water purification methods, Retein contributes to a resource-efficient and sustainable future.
Open Payments
Venture Round in 2023
Open Payments Europe is a developer of an open banking platform that facilitates secure access to various bank API networks across Europe. Established in 2017 and based in Stockholm, Sweden, the company offers a PSD2 compliant API aggregation platform, ensuring a unified and secure point of access for users. The platform is designed to allow third-party providers and business partners to create and manage their own products and services while maintaining control over the user experience. By using multi-language support and sample integrations, Open Payments enables businesses to seamlessly connect with banks and financial services, thereby enhancing the efficiency of their operations and fostering innovation in the financial sector.
Teitur Trophics
Series A in 2023
Teitur Trophics is a biotech company based in Aarhus, Denmark, established in 2020. The company focuses on developing circular peptides aimed at addressing neurodegenerative diseases. By studying small peptides that interact with receptors crucial for neural function, Teitur Trophics aims to understand the underlying biology and modulate key mechanisms involved in neural activity. This research is intended to support healthcare professionals in creating treatments that can prevent the onset of neurodegenerative conditions through daily injections.
ZeroPoint Technologies
Seed Round in 2023
ZeroPoint Technologies specializes in advanced memory compression technology that enhances energy efficiency and performance in data centers and smart devices. As energy consumption in the ICT sector rises, ZeroPoint's solutions address the need for improved performance per watt by eliminating unnecessary information from microchips. Their technology, which combines rapid data compression, real-time data compaction, and effective memory management, can deliver up to 50% more performance per watt. This innovation not only allows data centers to optimize energy usage but also enables smart device developers to enhance user experience without sacrificing battery life. With a strong patent portfolio and a foundation rooted in high-performance computing research, ZeroPoint collaborates with leading industry players to integrate its hardware IP into system-on-chip designs. The company, established by experts from academia and industry, has attracted talent from various sectors and successfully raised venture capital to support its growth and technological advancements.
Viking Analytics
Series A in 2023
Viking Analytics AB, based in Gothenburg, Sweden, develops advanced software solutions tailored for the manufacturing, chemical, and process industries. Established in 2012, the company specializes in its MultiViz analytics software, which assists industrial firms in preparing, analyzing, and organizing sensor data and condition monitoring information. This tool enables users to visualize data effectively, detect patterns, and monitor machine performance with greater reliability. Since 2018, Viking Analytics has focused on enhancing the capabilities of maintenance firms, original equipment manufacturers, and system integrators by identifying machines that require attention and providing insights into the reasons for their condition. By utilizing feedback from experts, the software continuously improves its performance, reducing false alarms and eliminating the need for companies to maintain their own artificial intelligence teams. Overall, Viking Analytics contributes to process optimization and minimizes unplanned maintenance interruptions through advanced anomaly detection and predictive analytics.
EnginZyme
Series B in 2022
EnginZyme AB is a biotechnology company based in Stockholm, Sweden, founded in 2014. The company specializes in biocatalysis and a cell-free synthetic biology platform to create sustainable alternatives to conventional materials such as plastics, nylons, and rubbers. EnginZyme's innovative approach focuses on biomanufacturing techniques that promote green chemistry across various industries, including pharmaceuticals, food, chemicals, flavors, and fragrances. By utilizing patented cell-free technology, EnginZyme aims to replace traditional fossil-based manufacturing, thus facilitating the shift toward environmentally friendly production methods. The company has gained recognition for its contributions to sustainability, being named a Global Cleantech 100 company and recognized as a Technology Pioneer by the World Economic Forum. EnginZyme is supported by a diverse group of investors, reflecting its potential impact on addressing climate change and promoting sustainable practices in manufacturing.
MinervaX
Series C in 2022
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.
Digip
Seed Round in 2022
Digip is a Swedish legal tech company specializing in software solutions for trademark registration and protection. Its platform offers an accessible and affordable approach to intellectual property management by digitizing traditional processes. With features designed for on-demand trademark registration and monitoring, Digip enables businesses and entrepreneurs to protect their brand names effectively in a user-friendly digital environment. By leveraging innovative technology and expertise, Digip aims to streamline the trademark protection process, reducing costs and enhancing the overall customer experience in managing intellectual property.
Occtoo
Seed Round in 2022
Occtoo AB is a software as a service company based in Vellinge, Sweden, that offers an Experience Data Platform aimed at enhancing digital experiences for retailers and brands. Founded in 2019, the platform enables marketers and content managers to easily orchestrate and personalize customer interactions by transforming enterprise data into actionable experience data. Occtoo provides no-code and low-code solutions that facilitate content personalization, dynamic product profiling, and customer insights, while also allowing for real-time data collection across various devices and channels. This technology streamlines the creation of applications and digital experiences, reducing the need for complex integrations. Notable clients include brands such as Cartier, Intersport, Fjällräven, and Filippa K, reflecting the platform's effectiveness in delivering tailored user experiences throughout the customer journey.
KISAB
Venture Round in 2022
KISAB is a partner of Mitronic IT services and is their local provider of office equipment and IT in technical service and sales. They offer sales, service, repairs, and accessories for most brands on the market, including Brother, Canon, Sharp, Olivetti, OKI, Lexmark, HP, Microsoft, and more.
AnaCardio
Series A in 2022
AnaCardio is a clinical-stage biopharmaceutical company focused on developing innovative drugs for the treatment of heart failure. The company’s therapeutic drugs aim to enhance the contractility of the heart muscle through a unique mechanism involving a therapeutic peptide. This approach is designed to avoid common adverse effects associated with heart treatments, such as tachycardia, arrhythmia, ischemia, and hypotension. By improving cardiac output safely, AnaCardio's therapies have the potential to enhance organ function, boost quality of life, increase functional capacity, and reduce the risk of hospitalization and mortality in patients with heart failure.
Airsonett
Venture Round in 2022
Airsonett is a medical device company focused on developing non-pharmaceutical treatments for allergic asthma and eczema. Its flagship product, the Air4, utilizes patented Temperature-controlled Laminar Airflow (TLA) technology to significantly reduce allergens and airborne irritants in a patient's breathing zone during rest and sleep. This innovative home medical device aims to provide relief for individuals suffering from allergic asthma and atopic eczema, primarily serving patients in Sweden and the UK. By offering a non-invasive solution, Airsonett addresses the need for effective prophylactic treatments without relying on traditional medication.
Nextory AB is a Swedish company based in Kista that operates a mobile application offering a subscription service for access to a wide range of e-books and audiobooks. The platform allows users to download and listen to stories in both PDF and audio formats, providing a comprehensive digital library that enhances the reading experience. By enabling clients to explore a diverse catalog of literary content, Nextory aims to make reading more accessible and enjoyable through the convenience of smartphones and tablets.
Elypta
Series A in 2022
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, specializing in the development of a metabolism-based liquid biopsy platform aimed at the early detection and monitoring of cancer. Founded in 2017, the company focuses on measuring biomarkers in blood and urine, employing machine learning and artificial intelligence algorithms to identify cancer signatures. Elypta is actively conducting the AURORAX clinical trial series to explore applications for its platform, particularly in renal cell carcinoma, while also investigating other cancer indications. The technology includes a new in vitro diagnostic laboratory assay kit, which enables comprehensive profiling of glycosaminoglycan metabolites and supports a range of applications from screening to treatment response monitoring, facilitating earlier interventions in cancer care.
ShardSecure
Series A in 2022
ShardSecure, Inc. is a data protection company that specializes in cloud data security solutions. Founded in 2019 and headquartered in New York, ShardSecure utilizes its proprietary Microshard technology to enhance the security of sensitive data stored and shared in the cloud. This technology fragments data into small pieces that are distributed across multiple cloud environments and combined with false shards, making it nearly impossible for cybercriminals to reassemble the original information. By deploying as a virtual storage appliance, Microshard serves as an application-agnostic solution that provides an additional layer of defense against potential misconfigurations in cloud settings. ShardSecure integrates with major cloud service providers such as AWS, Azure, Google, and IBM, offering enterprises and government agencies a simplified approach to data security without the complexities associated with traditional encryption methods.
Peafowl Plasmonics
Seed Round in 2022
Peafowl Plasmonics specializes in innovative solar cell technology that is highly transparent, efficient, and sustainable. The company has developed plasmonic solar cells capable of absorbing light in various conditions, whether in harsh outdoor environments or low-illumination indoor settings. This technology not only enhances energy efficiency but also allows for the direct integration of sensors into window glass without the need for wires or batteries. By enabling commercial partners and customers to reduce energy consumption and carbon emissions, Peafowl Plasmonics actively contributes to lowering corporate carbon footprints and promoting sustainable energy solutions.
Asgard Therapeutics
Seed Round in 2021
Asgard Therapeutics is a private biotech company focused on developing innovative cancer immunotherapies through direct cell reprogramming technologies. Emerging as a spin-off from Lund University, the company utilizes its proprietary TrojanDC technology to initiate immune responses by leveraging the unique properties of professional antigen-presenting cells. This approach aims to create efficient and personalized gene therapy products that activate robust anti-cancer immune defenses. By offering off-the-shelf solutions, Asgard Therapeutics seeks to provide new treatment options for patients suffering from cancers that are resistant to traditional therapies, thereby expanding the possibilities for effective cancer treatment.
TrusTrace
Series A in 2021
TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.
Funnel
Series C in 2021
Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.
ZeroPoint Technologies
Seed Round in 2021
ZeroPoint Technologies specializes in advanced memory compression technology that enhances energy efficiency and performance in data centers and smart devices. As energy consumption in the ICT sector rises, ZeroPoint's solutions address the need for improved performance per watt by eliminating unnecessary information from microchips. Their technology, which combines rapid data compression, real-time data compaction, and effective memory management, can deliver up to 50% more performance per watt. This innovation not only allows data centers to optimize energy usage but also enables smart device developers to enhance user experience without sacrificing battery life. With a strong patent portfolio and a foundation rooted in high-performance computing research, ZeroPoint collaborates with leading industry players to integrate its hardware IP into system-on-chip designs. The company, established by experts from academia and industry, has attracted talent from various sectors and successfully raised venture capital to support its growth and technological advancements.
Limina Investment Management Solution
Series A in 2021
Limina Investment Management Solution (IMS) is a Front-to-Middle Office Solution that let investment managers focus on what matters: producing investment returns with minimal operational risk. The open platform help Asset Managers overcome fragmented workflows and increase confidence in data and oversight. Limina was founded by former investment managers that set out to create a solution to the challenges they faced. The solution now offered by Limina is engineered in Sweden and delivered by industry experts globally.
Hopsworks
Series A in 2021
Hopsworks, founded in 2016 and based in Stockholm, Sweden, is a developer of a data platform that focuses on artificial intelligence and machine learning. The company offers Hops Enterprise Services, which utilizes deep learning, stream processing, and SQL capabilities. Hopsworks provides an on-premise data management and data science platform called Hopsworks Enterprise, which includes tools for planning, pricing, and calculating return on investment for data scientists. The platform is designed to support the development and management of feature, training, and inference pipelines at scale, catering to diverse data teams and sources. Hopsworks specializes in technologies such as TensorFlow, Flink, MySQL, and HDFS, enabling clients to implement AI solutions for complex business challenges with optimal performance and availability.
ShardSecure
Seed Round in 2021
ShardSecure, Inc. is a data protection company that specializes in cloud data security solutions. Founded in 2019 and headquartered in New York, ShardSecure utilizes its proprietary Microshard technology to enhance the security of sensitive data stored and shared in the cloud. This technology fragments data into small pieces that are distributed across multiple cloud environments and combined with false shards, making it nearly impossible for cybercriminals to reassemble the original information. By deploying as a virtual storage appliance, Microshard serves as an application-agnostic solution that provides an additional layer of defense against potential misconfigurations in cloud settings. ShardSecure integrates with major cloud service providers such as AWS, Azure, Google, and IBM, offering enterprises and government agencies a simplified approach to data security without the complexities associated with traditional encryption methods.
Fast Travel Games
Series B in 2021
Fast Travel Games is a game development studio based in Stockholm, Sweden, specializing in virtual reality (VR) games. Founded by experienced professionals from notable studios such as EA DICE, Rovio, and Avalanche, the company aims to transform the gaming experience through immersive VR environments. They focus on creating games that promote exploration, rich narratives, and social interaction, allowing players to engage with their surroundings and each other in innovative ways. Fast Travel Games is dedicated to delivering engaging experiences that enhance the way players connect with gaming universes.
Digip
Seed Round in 2021
Digip is a Swedish legal tech company specializing in software solutions for trademark registration and protection. Its platform offers an accessible and affordable approach to intellectual property management by digitizing traditional processes. With features designed for on-demand trademark registration and monitoring, Digip enables businesses and entrepreneurs to protect their brand names effectively in a user-friendly digital environment. By leveraging innovative technology and expertise, Digip aims to streamline the trademark protection process, reducing costs and enhancing the overall customer experience in managing intellectual property.
NuvoAir Medical
Series A in 2021
NuvoAir AB, founded in 2015 and based in Stockholm, Sweden, is a medical technology company focused on monitoring lung function through its Air Next home spirometer. The company operates an online platform to provide its products and services. NuvoAir Medical offers a comprehensive care model that integrates advanced monitoring technology and analytics with evidence-based interventions for managing chronic heart and lung conditions. This approach emphasizes personalized care, delivered by a multidisciplinary team, and collaborates with health plans and risk-bearing entities to implement flexible payment arrangements. By focusing on value-based specialty management, NuvoAir aims to improve patient outcomes while reducing healthcare costs.
Exeri
Venture Round in 2021
Exeri AB, founded in 2009 and based in Luleå, Sweden, specializes in transforming traditional electric grids into Smart Grids through its innovative Smart Grid Surveillance (SGS) system. This comprehensive technology digitizes electric grid networks, enabling real-time monitoring and providing network owners with up-to-date information on their systems. Exeri's solution enhances the security of electricity networks by facilitating quick problem detection and reducing power outage durations. Utilizing IoT technology and AI-driven algorithms, the system offers precise error localization, predictive maintenance capabilities, and decision support tools. This not only improves the efficiency of electricity grids but also supports the integration of renewable energy sources and the charging of electric vehicles, contributing to a sustainable energy future.
Lexly
Venture Round in 2021
Lexly is a prominent player in the Nordic legal tech market, offering online legal services that provide specialized legal advice around the clock. The company focuses on various legal matters, including wills, gift deeds, and stockholder agreements. Lexly also features an online legal tool designed to help individuals create their legal documents efficiently. By streamlining the process of obtaining legal assistance, Lexly enables customers to minimize legal costs while enhancing overall efficiency. The group also encompasses brands such as Stirling Blue and Pactumize, further solidifying its position in the industry.
Meniga
Venture Round in 2021
Meniga Ltd is a London-based company that specializes in developing white-label digital banking solutions aimed at enhancing personal finance management for banks, businesses, and individuals. Established in 2013, Meniga offers a comprehensive suite of products, including data aggregation, automated real-time notifications, predictive analytics, and personalized engagement tools. Its platform is designed to provide meaningful customer interactions and unlock new revenue opportunities through advanced data consolidation and enrichment. Additionally, Meniga facilitates cashback rewards and transaction-based carbon insights, allowing users to manage financial data efficiently while promoting sustainability. The company's modular and customizable solutions cater to the diverse needs of financial institutions, reinforcing their customer relationships and improving the overall online and mobile banking experience.
Crosser
Venture Round in 2021
Crosser specializes in the design and development of streaming analytics and integration software suitable for edge, fog, or cloud environments. The Crosser platform facilitates real-time processing of both streaming and batch data, supporting applications in industrial IoT, data transformation, analytics, automation, and integration. By offering real-time analytics and decision-making capabilities, the platform is particularly beneficial for enterprises in sectors such as healthcare, industrial IoT, and smart buildings. This technology helps organizations minimize cloud service usage and reduce bandwidth costs, enhancing operational efficiency and effectiveness.
EnginZyme
Series A in 2021
EnginZyme AB is a biotechnology company based in Stockholm, Sweden, founded in 2014. The company specializes in biocatalysis and a cell-free synthetic biology platform to create sustainable alternatives to conventional materials such as plastics, nylons, and rubbers. EnginZyme's innovative approach focuses on biomanufacturing techniques that promote green chemistry across various industries, including pharmaceuticals, food, chemicals, flavors, and fragrances. By utilizing patented cell-free technology, EnginZyme aims to replace traditional fossil-based manufacturing, thus facilitating the shift toward environmentally friendly production methods. The company has gained recognition for its contributions to sustainability, being named a Global Cleantech 100 company and recognized as a Technology Pioneer by the World Economic Forum. EnginZyme is supported by a diverse group of investors, reflecting its potential impact on addressing climate change and promoting sustainable practices in manufacturing.
Occtoo
Seed Round in 2021
Occtoo AB is a software as a service company based in Vellinge, Sweden, that offers an Experience Data Platform aimed at enhancing digital experiences for retailers and brands. Founded in 2019, the platform enables marketers and content managers to easily orchestrate and personalize customer interactions by transforming enterprise data into actionable experience data. Occtoo provides no-code and low-code solutions that facilitate content personalization, dynamic product profiling, and customer insights, while also allowing for real-time data collection across various devices and channels. This technology streamlines the creation of applications and digital experiences, reducing the need for complex integrations. Notable clients include brands such as Cartier, Intersport, Fjällräven, and Filippa K, reflecting the platform's effectiveness in delivering tailored user experiences throughout the customer journey.
MinervaX
Series B in 2020
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.
Avassa
Funding Round in 2020
Avassa is a developer of a distributed cloud management platform focused on managing applications across various edge locations. The platform facilitates secure and remote updates, monitoring, and troubleshooting of edge applications, streamlining application orchestration while adhering to a zero-trust security model. By bridging the gap between containerized application development and operations, Avassa's solution allows businesses to deploy teams, monitor workloads, and manage the lifecycle of edge applications efficiently and securely. This approach empowers organizations to operate at the speed of software while ensuring robust management in diverse environments.
InRiver
Venture Round in 2020
inRiver AB develops a product information management (PIM) software solution that enables branded manufacturers, industrial manufacturers, and retailers to create, manage, and distribute product information effectively. The company serves B2C and B2B multi-channel commerce professionals, enhancing their ability to drive online sales and maintain customer satisfaction. Founded in 2003 and headquartered in Malmö, Sweden, inRiver has established regional offices in Chicago, Amsterdam, and Stockholm, along with sales offices in various global locations. The platform allows organizations to turn product information into strategic assets by uniformly presenting sales materials, such as videos, text, and images, across multiple channels and languages. With over 1,000 brands and 400 customers in 19 countries, inRiver helps businesses increase revenue and strengthen brand equity.
Open Payments
Seed Round in 2020
Open Payments Europe is a developer of an open banking platform that facilitates secure access to various bank API networks across Europe. Established in 2017 and based in Stockholm, Sweden, the company offers a PSD2 compliant API aggregation platform, ensuring a unified and secure point of access for users. The platform is designed to allow third-party providers and business partners to create and manage their own products and services while maintaining control over the user experience. By using multi-language support and sample integrations, Open Payments enables businesses to seamlessly connect with banks and financial services, thereby enhancing the efficiency of their operations and fostering innovation in the financial sector.
Gesynta Pharma
Series C in 2020
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.
Meniga
Corporate Round in 2020
Meniga Ltd is a London-based company that specializes in developing white-label digital banking solutions aimed at enhancing personal finance management for banks, businesses, and individuals. Established in 2013, Meniga offers a comprehensive suite of products, including data aggregation, automated real-time notifications, predictive analytics, and personalized engagement tools. Its platform is designed to provide meaningful customer interactions and unlock new revenue opportunities through advanced data consolidation and enrichment. Additionally, Meniga facilitates cashback rewards and transaction-based carbon insights, allowing users to manage financial data efficiently while promoting sustainability. The company's modular and customizable solutions cater to the diverse needs of financial institutions, reinforcing their customer relationships and improving the overall online and mobile banking experience.
Trialbee
Venture Round in 2020
Trialbee AB is a software company based in Malmö, Sweden, established in 2010. It specializes in creating a software as a service (SaaS) solution aimed at enhancing patient matching and engagement for clinical trials. The company focuses on improving the speed and accuracy of patient recruitment through its platform, which allows candidates to search for various clinical trials and offers services such as awareness, pre-screening, and reporting. Trialbee provides comprehensive support for sponsors, contract research organizations (CROs), investigator sites, and patients by offering patient recruitment, enrollment, and retention services, including a resource library and adherence reminders. Its technology is designed to simplify clinical research as a care option, ultimately accelerating drug development for pharmaceutical companies.
DbVis Software
Venture Round in 2020
DbVis Software AB, founded in 2003 and based in Stockholm, Sweden, specializes in developing database management and analysis software. Its flagship product, DbVisualizer, serves as a platform-independent tool that connects to various data sources, allowing users to manage database-specific objects and perform tasks such as creating, editing, and compiling procedures, functions, and triggers. The software also facilitates schema exports and the comparison of editors and result sets. DbVis Software emphasizes user feedback in its development process, ensuring that new features are added thoughtfully. The company offers dedicated support directly from its development team, maintaining a transparent and competitive pricing model that includes a free version of DbVisualizer, as well as discounts for educational and non-profit institutions. With over 6 million downloads and adoption by more than 28,000 companies across 145 countries, DbVis Software is committed to providing high-quality tools that enhance the efficiency of database users.
Nextory
Venture Round in 2020
Nextory AB is a Swedish company based in Kista that operates a mobile application offering a subscription service for access to a wide range of e-books and audiobooks. The platform allows users to download and listen to stories in both PDF and audio formats, providing a comprehensive digital library that enhances the reading experience. By enabling clients to explore a diverse catalog of literary content, Nextory aims to make reading more accessible and enjoyable through the convenience of smartphones and tablets.
Barnebys
Venture Round in 2020
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.
Elypta
Seed Round in 2020
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, specializing in the development of a metabolism-based liquid biopsy platform aimed at the early detection and monitoring of cancer. Founded in 2017, the company focuses on measuring biomarkers in blood and urine, employing machine learning and artificial intelligence algorithms to identify cancer signatures. Elypta is actively conducting the AURORAX clinical trial series to explore applications for its platform, particularly in renal cell carcinoma, while also investigating other cancer indications. The technology includes a new in vitro diagnostic laboratory assay kit, which enables comprehensive profiling of glycosaminoglycan metabolites and supports a range of applications from screening to treatment response monitoring, facilitating earlier interventions in cancer care.
Funnel
Series B in 2020
Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.
ShardSecure
Seed Round in 2019
ShardSecure, Inc. is a data protection company that specializes in cloud data security solutions. Founded in 2019 and headquartered in New York, ShardSecure utilizes its proprietary Microshard technology to enhance the security of sensitive data stored and shared in the cloud. This technology fragments data into small pieces that are distributed across multiple cloud environments and combined with false shards, making it nearly impossible for cybercriminals to reassemble the original information. By deploying as a virtual storage appliance, Microshard serves as an application-agnostic solution that provides an additional layer of defense against potential misconfigurations in cloud settings. ShardSecure integrates with major cloud service providers such as AWS, Azure, Google, and IBM, offering enterprises and government agencies a simplified approach to data security without the complexities associated with traditional encryption methods.
Combinostics
Series A in 2019
Combinostics Oy is a Finnish company founded in 2014, specializing in advanced diagnostic tools aimed at neurodegenerative diseases. The company develops software solutions that support clinical decision-making by providing quantitative assessments of brain images, including MR, PET, and CT scans. Through its cloud-based platform, Combinostics offers healthcare professionals a comprehensive view of patient data, facilitating early diagnosis and enhancing treatment outcomes for neurological disorders. By integrating imaging biomarker solutions with clinical decision support, Combinostics aims to improve the accuracy and efficiency of diagnostics in the healthcare sector.
Freemelt
Seed Round in 2019
Freemelt AB, founded in 2017 and based in Mölndal, Sweden, specializes in the development and manufacture of metal 3D printers, with its flagship product being the Freemelt One. This printer utilizes an electron beam melting (EBM) platform and is designed for open-source, materials-innovation in additive manufacturing. Freemelt enables customers to create and test their own materials, providing a diverse range of options including oxygen-free high-conductivity copper, intermetallics, various steels, and nickel-based superalloys. The company focuses on serving research-scale material development, offering comprehensive support in production, marketing, sales, and servicing of its technology.
Ingrid Cloud
Venture Round in 2019
Ingrid Cloud AB, based in Stockholm, Sweden, specializes in a cloud-based computational application designed for wind simulation. Founded in 2014, the company offers an automated platform that streamlines the flow simulation and design optimization process. By converting computer-aided design (CAD) geometry into complex simulation models without requiring manual intervention, Ingrid Cloud's technology enhances accuracy, flexibility, and cost efficiency. This user-friendly service allows designers, architects, engineers, and researchers, even those without prior knowledge of computational fluid dynamics, to effectively predict flow and refine their designs.
Crosser
Series A in 2019
Crosser specializes in the design and development of streaming analytics and integration software suitable for edge, fog, or cloud environments. The Crosser platform facilitates real-time processing of both streaming and batch data, supporting applications in industrial IoT, data transformation, analytics, automation, and integration. By offering real-time analytics and decision-making capabilities, the platform is particularly beneficial for enterprises in sectors such as healthcare, industrial IoT, and smart buildings. This technology helps organizations minimize cloud service usage and reduce bandwidth costs, enhancing operational efficiency and effectiveness.
Athera Biotechnologies
Venture Round in 2019
Athera Biotechnologies AB is a biopharmaceutical company based in Stockholm, Sweden, dedicated to developing targeted anti-inflammatory therapies and companion diagnostics for cardiovascular diseases (CVD). Founded in 2002, the company focuses on identifying immunological markers associated with atherosclerosis to enhance prevention and treatment strategies for CVD. Its product portfolio includes CVDefine, an immunological marker and ELISA kit designed for cardiovascular risk assessment, as well as innovative biopharmaceuticals like Annexin A5, which aims to prevent plaque rupture, and PC-mAb, a monoclonal antibody therapy targeting the uptake of oxidized LDL in macrophages. Athera's development efforts are grounded in research from the Karolinska Institutet and aim to meet the significant unmet medical needs in anti-inflammatory therapeutics for vascular diseases.
NuvoAir Medical
Venture Round in 2019
NuvoAir AB, founded in 2015 and based in Stockholm, Sweden, is a medical technology company focused on monitoring lung function through its Air Next home spirometer. The company operates an online platform to provide its products and services. NuvoAir Medical offers a comprehensive care model that integrates advanced monitoring technology and analytics with evidence-based interventions for managing chronic heart and lung conditions. This approach emphasizes personalized care, delivered by a multidisciplinary team, and collaborates with health plans and risk-bearing entities to implement flexible payment arrangements. By focusing on value-based specialty management, NuvoAir aims to improve patient outcomes while reducing healthcare costs.
Gesynta Pharma
Seed Round in 2019
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.
Funnel
Venture Round in 2019
Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.
Formulate
Venture Round in 2018
Formulate AB operates a marketing analytics platform that assists retail merchandising teams in optimizing promotional performance. Founded in 2015 and based in Stockholm, Sweden, the company provides a cloud-based solution known as Formulate Decision Cloud, which leverages an advanced AI engine to transform sales data into actionable insights. By processing large volumes of business data, the platform offers analytics and competitive intelligence that facilitate better decision-making in campaign management. Additionally, the tool True Lift is designed to enhance the understanding of marketing outcomes, enabling retailers to analyze and forecast the effectiveness of their promotions.
Apica
Series D in 2018
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.
DPOrganizer
Series A in 2018
DPOrganizer is a privacy management software company founded in 2015 and headquartered in Stockholm, Sweden. The software is designed to assist professionals throughout the privacy program lifecycle by enabling them to map, visualize, report, and manage the processing of personal data. This functionality helps clients improve control and compliance with privacy regulations, reduce risks, and utilize internal resources more efficiently. The platform aims to facilitate better collaboration and communication within organizations, ultimately supporting their growth in compliance with GDPR and other privacy requirements.
Trialbee
Venture Round in 2018
Trialbee AB is a software company based in Malmö, Sweden, established in 2010. It specializes in creating a software as a service (SaaS) solution aimed at enhancing patient matching and engagement for clinical trials. The company focuses on improving the speed and accuracy of patient recruitment through its platform, which allows candidates to search for various clinical trials and offers services such as awareness, pre-screening, and reporting. Trialbee provides comprehensive support for sponsors, contract research organizations (CROs), investigator sites, and patients by offering patient recruitment, enrollment, and retention services, including a resource library and adherence reminders. Its technology is designed to simplify clinical research as a care option, ultimately accelerating drug development for pharmaceutical companies.
Fishbrain
Series B in 2018
Fishbrain is a mobile application and commerce platform designed for fishing enthusiasts. It serves as a social network that connects anglers globally, allowing users to share information about catches and fishing techniques. The app features an interactive map that helps users discover new fishing locations and see what other anglers are catching, including details on bait used and specific locations. Fishbrain promotes responsible fishing practices, encouraging catch and release as well as the sustainable harvest of fish species. Additionally, the platform offers tools and insights to enhance the fishing experience, supporting users in their pursuit of successful fishing adventures.
DPOrganizer
Series A in 2017
DPOrganizer is a privacy management software company founded in 2015 and headquartered in Stockholm, Sweden. The software is designed to assist professionals throughout the privacy program lifecycle by enabling them to map, visualize, report, and manage the processing of personal data. This functionality helps clients improve control and compliance with privacy regulations, reduce risks, and utilize internal resources more efficiently. The platform aims to facilitate better collaboration and communication within organizations, ultimately supporting their growth in compliance with GDPR and other privacy requirements.
Barnebys
Venture Round in 2017
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.
Adfenix
Series A in 2017
Adfenix AB is a Swedish company founded in 2014 and headquartered in Gothenburg. It specializes in developing a social media advertising platform tailored for real estate agents, enabling them to attract new customers through targeted advertising. The Adfenix platform leverages real estate data to empower agents, enhancing their ability to assist consumers in the home-buying journey. By providing quality advertising products and related services, Adfenix simplifies the marketing process for real estate professionals, allowing them to engage effectively with potential clients.
Funnel
Series A in 2017
Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.
Starcounter
Venture Round in 2017
Starcounter, founded in 2006 by Joachim Wester, is a privately held company based in Stockholm, Sweden, with additional offices in Gdansk, Poland, and Palo Alto, USA. The company specializes in developing a database management platform aimed at revitalizing enterprise software systems. Its innovative platform integrates an in-memory database engine with an application server, facilitating the creation of high-performance business applications. Starcounter's research and development team, composed of over 30 experts in artificial intelligence, mathematics, and algorithms from seven different countries, drives the company's advancements in technology. By leveraging artificial intelligence and in-memory computing, Starcounter enhances the efficiency and performance of software applications for enterprises.
Fast Travel Games
Series A in 2017
Fast Travel Games is a game development studio based in Stockholm, Sweden, specializing in virtual reality (VR) games. Founded by experienced professionals from notable studios such as EA DICE, Rovio, and Avalanche, the company aims to transform the gaming experience through immersive VR environments. They focus on creating games that promote exploration, rich narratives, and social interaction, allowing players to engage with their surroundings and each other in innovative ways. Fast Travel Games is dedicated to delivering engaging experiences that enhance the way players connect with gaming universes.
Apica
Venture Round in 2017
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.
Athera Biotechnologies
Venture Round in 2017
Athera Biotechnologies AB is a biopharmaceutical company based in Stockholm, Sweden, dedicated to developing targeted anti-inflammatory therapies and companion diagnostics for cardiovascular diseases (CVD). Founded in 2002, the company focuses on identifying immunological markers associated with atherosclerosis to enhance prevention and treatment strategies for CVD. Its product portfolio includes CVDefine, an immunological marker and ELISA kit designed for cardiovascular risk assessment, as well as innovative biopharmaceuticals like Annexin A5, which aims to prevent plaque rupture, and PC-mAb, a monoclonal antibody therapy targeting the uptake of oxidized LDL in macrophages. Athera's development efforts are grounded in research from the Karolinska Institutet and aim to meet the significant unmet medical needs in anti-inflammatory therapeutics for vascular diseases.
InRiver
Venture Round in 2017
inRiver AB develops a product information management (PIM) software solution that enables branded manufacturers, industrial manufacturers, and retailers to create, manage, and distribute product information effectively. The company serves B2C and B2B multi-channel commerce professionals, enhancing their ability to drive online sales and maintain customer satisfaction. Founded in 2003 and headquartered in Malmö, Sweden, inRiver has established regional offices in Chicago, Amsterdam, and Stockholm, along with sales offices in various global locations. The platform allows organizations to turn product information into strategic assets by uniformly presenting sales materials, such as videos, text, and images, across multiple channels and languages. With over 1,000 brands and 400 customers in 19 countries, inRiver helps businesses increase revenue and strengthen brand equity.
Sol Voltaics
Series D in 2017
Sol Voltaics AB is a nanotechnology company based in Lund, Sweden, that specializes in enhancing the efficiency of solar energy capture and generation. Established in 2007, the company develops and commercializes innovative nanomaterials, particularly through its flagship product, SolFilm. This solar panel additive, composed of gallium arsenide nanowires, is designed to improve the performance of conventional silicon solar modules. SolFilm is lightweight and transparent to infrared light, allowing it to convert high-energy sunlight directly into electricity while enabling additional power generation through underlying solar cells in a stacked configuration. By integrating these advanced technologies, Sol Voltaics aims to significantly boost the efficiency of photovoltaic modules, potentially increasing their output by up to 50%.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.